Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
1(9%)
Results Posted
14%(1 trials)

Phase Distribution

Ph phase_3
1
9%
Ph phase_2
1
9%
Ph not_applicable
9
82%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution11 total trials
Phase 2Efficacy & side effects
1(9.1%)
Phase 3Large-scale testing
1(9.1%)
N/ANon-phased studies
9(81.8%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(3)
Completed(7)
Other(1)

Detailed Status

Completed7
Active, not recruiting1
Enrolling by invitation1
Not yet recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (9.1%)
Phase 31 (9.1%)
N/A9 (81.8%)

Trials by Status

active_not_recruiting19%
enrolling_by_invitation19%
completed764%
not_yet_recruiting19%
unknown19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
11